-
by Patrick Eckstrom
Partnership will Create Patented Products for the Treatment of Neuroinflammatory Disorders
VANCOUVER, BC, Oct. 19, 2021 /PRNewswire/ - October 19, ...
-
by Patrick Eckstrom
Mycrodose Therapeutics successfully closes oversubscribed seven-figure financing round.
Financing was funded by multiple high profile institutio...
-
by Patrick Eckstrom
San Diego, California--(Newsfile Corp. - September 2, 2021) - Mycrodose Therapeutics, a US pharmaceutical company focused on developing advanced dr...
-
by Patrick Eckstrom
Mycrodose Therapeutics is pleased to announce that the company has been approved by the United States Drug Enforcement Agency (DEA), State of Calif...
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device